Adaptive Biotechnologies Corporation · DUS:1HM
Adaptive Biotechnologies Corporation shareholders
As of Sep 30, 2026, 321 institutions reported holding Adaptive Biotechnologies Corporation. Largest: Viking Global Investors LP, BlackRock and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
Shareholders
Institutions
| Holder | Shares | Value | As of |
|---|---|---|---|
| Viking Global Investors LP | 30M | US$867M | Sep 30, 2026 |
| BlackRock | 15.3M | US$442M | Sep 30, 2026 |
| Vanguard | 12.8M | US$371M | Sep 30, 2026 |
| T. Rowe Price | 9.29M | US$268M | Sep 30, 2026 |
| D. E. Shaw & Co., Inc. | 6.37M | US$184M | Sep 30, 2026 |
| Wellington | 4.75M | US$137M | Sep 30, 2026 |
| Driehaus Capital Management LLC | 4.71M | US$136M | Sep 30, 2026 |
| Geode Capital | 3.72M | US$108M | Sep 30, 2026 |
| State Street | 3.56M | US$103M | Sep 30, 2026 |
| Lord, Abbett & Co. LLC | 3.32M | US$95.9M | Sep 30, 2026 |
| Invesco | 3.23M | US$93.3M | Sep 30, 2026 |
| Goldman Sachs | 3.09M | US$89.2M | Sep 30, 2026 |
| BNP Paribas | 3.08M | US$89M | Sep 30, 2026 |
| Principal | 2.45M | US$70.7M | Sep 30, 2026 |
| Nuveen | 2.34M | US$67.7M | Sep 30, 2026 |
| Arrowstreet Capital, Limited Partnership | 2.31M | US$66.8M | Sep 30, 2026 |
| Fred Alger Management, LLC | 2.08M | US$60M | Sep 30, 2026 |
| ARK | 1.92M | US$55.5M | Sep 30, 2026 |
| UBS | 1.86M | US$53.8M | Sep 30, 2026 |
| Aristotle Atlantic Partners, LLC | 1.85M | US$53.6M | Sep 30, 2026 |
| Westfield Capital Management Co LP | 1.83M | US$52.8M | Sep 30, 2026 |
| Northern Trust | 1.53M | US$44.2M | Sep 30, 2026 |
| Oberweis Asset Management Inc/ | 1.26M | US$36.3M | Sep 30, 2026 |
| Schwab | 1.24M | US$36M | Sep 30, 2026 |
| Millennium | 1.22M | US$35.1M | Sep 30, 2026 |
| Nomura | 1.21M | US$35.1M | Sep 30, 2026 |
| Bank of America | 1.14M | US$33.1M | Sep 30, 2026 |
| Ameriprise | 1.13M | US$32.7M | Sep 30, 2026 |
| Amova Asset Management Americas, Inc. | 1.09M | US$31.4M | Sep 30, 2026 |
| Sumitomo Mitsui Trust Group, Inc. | 1.09M | US$31.4M | Sep 30, 2026 |
| Morgan Stanley | 1.05M | US$30.4M | Sep 30, 2026 |
| BNY | 1.03M | US$29.8M | Sep 30, 2026 |
| Panagora Asset Management Inc | 1.02M | US$29.5M | Sep 30, 2026 |
| Blue Water Life Science Advisors, LP | 1.01M | US$29.2M | Sep 30, 2026 |
| Connor, Clark & Lunn Investment Management Ltd. | 947K | US$27.4M | Sep 30, 2026 |
| Renaissance Technologies | 867K | US$25.1M | Sep 30, 2026 |
| Fidelity | 833K | US$24.1M | Sep 30, 2026 |
| First Trust | 797K | US$23M | Sep 30, 2026 |
| abrdn | 783K | US$22.6M | Sep 30, 2026 |
| Mackenzie | 740K | US$21.4M | Sep 30, 2026 |
| Sun Life | 708K | US$20.4M | Sep 30, 2026 |
| Franklin Templeton | 705K | US$18.8M | Sep 30, 2026 |
| Qube Research & Technologies Ltd | 696K | US$20.1M | Sep 30, 2026 |
| Susquehanna | 634K | US$18.3M | Sep 30, 2026 |
| Point72 Asset Management, L.P. | 630K | US$18.2M | Sep 30, 2026 |
| Granite Investment Partners, LLC | 628K | US$18.2M | Sep 30, 2026 |
| Next Century Growth Investors LLC | 623K | US$18M | Sep 30, 2026 |
| Jennison Associates LLC | 612K | US$17.7M | Sep 30, 2026 |
| Parkman Healthcare Partners LLC | 600K | US$17.3M | Sep 30, 2026 |
| Hillsdale Investment Management Inc. | 551K | US$15.9M | Sep 30, 2026 |
This page holds 50 of 321 holders.
Funds
This page holds 50 of 277 holders.
Big stakes
| Stake | Stake | Shares | Date | Filing |
|---|---|---|---|---|
| Viking Global Investors LP | 18.80% | 30M | Mar 31, 2026 | Schedule 13G |
| BlackRock, Inc. | 7.90% | 12M | Dec 31, 2025 | Schedule 13G |